Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 1989; Volume 35,Issue 6
  • You have access
    Studies on the mechanism of methanol poisoning: purification and comparison of rat and human liver 10-formyltetrahydrofolate dehydrogenase.
    F C Johlin, E Swain, C Smith and T R Tephly
    Molecular Pharmacology June 1989, 35 (6) 745-750;
  • You have access
    Solubilization and characterization of the pyrilamine-binding protein from cultured smooth muscle cells.
    M Mitsuhashi and D G Payan
    Molecular Pharmacology June 1989, 35 (6) 751-759;
  • You have access
    Thyroid hormones directly interact with vascular smooth muscle strips.
    T Ishikawa, T Chijiwa, M Hagiwara, S Mamiya and H Hidaka
    Molecular Pharmacology June 1989, 35 (6) 760-765;
  • You have access
    SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
    A Schmid, G Romey, J Barhanin and M Lazdunski
    Molecular Pharmacology June 1989, 35 (6) 766-773;
  • You have access
    Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    M Amiche, S Sagan, A Mor, A Delfour and P Nicolas
    Molecular Pharmacology June 1989, 35 (6) 774-779;
  • You have access
    Affinity chromatography of A1 adenosine receptors of rat brain membranes.
    H Nakata
    Molecular Pharmacology June 1989, 35 (6) 780-786;
  • You have access
    A phencyclidine recognition site is associated with N-methyl-D-aspartate inhibition of carbachol-stimulated phosphoinositide hydrolysis in rat cortical slices.
    R A Gonzales and J M Moerschbaecher
    Molecular Pharmacology June 1989, 35 (6) 787-794;
  • You have access
    Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.
    B P O'Sullivan and S Mong
    Molecular Pharmacology June 1989, 35 (6) 795-802;
  • You have access
    Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    R S Chang, T B Chen, M G Bock, R M Freidinger, R Chen, A Rosegay and V J Lotti
    Molecular Pharmacology June 1989, 35 (6) 803-808;
  • You have access
    Divalent cation-induced interconversion of hepatic angiotensin receptor subtypes.
    J McQueen and P F Semple
    Molecular Pharmacology June 1989, 35 (6) 809-817;
  • You have access
    Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase) with 5'-[p-(fluorosulfonyl)benzoyl]-adenosine.
    X F Liu, H Yuan, M Haniu, T Iyanagi, J E Shively and S A Chen
    Molecular Pharmacology June 1989, 35 (6) 818-822;
  • You have access
    Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene.
    A B Okey, L M Vella and P A Harper
    Molecular Pharmacology June 1989, 35 (6) 823-830;
  • You have access
    Inducible bilirubin-degrading system in the microsomal fraction of rat liver.
    F De Matteis, T Trenti, A H Gibbs and J B Greig
    Molecular Pharmacology June 1989, 35 (6) 831-838;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 35, Issue 6
1 Jun 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics